Galle Liz 4
4 · CVRx, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
Galle Liz
VP of Global Clinical Research
Transactions
- Award
Stock Option (right to buy)
2022-01-18+25,900→ 25,900 totalExercise: $9.08Exp: 2032-01-17→ Common Stock (25,900 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.